201 related articles for article (PubMed ID: 24124694)
1. Concern for truth: driving defensively when confronting a zombie epidemic.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Nov; 51(11):9-12. PubMed ID: 24124694
[TBL] [Abstract][Full Text] [Related]
2. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.
Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV
N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939
[No Abstract] [Full Text] [Related]
3. Safety of drug therapy for nausea and vomiting of pregnancy.
Huff PS
J Fam Pract; 1980 Nov; 11(6):969-70. PubMed ID: 7005391
[No Abstract] [Full Text] [Related]
4. Debendox is not thalidomide.
Lancet; 1984 Jul; 2(8396):205-6. PubMed ID: 6146759
[No Abstract] [Full Text] [Related]
5. Fetal malformation after Debendox treatment in early pregnancy.
Br Med J; 1978 Apr; 1(6119):1055-6. PubMed ID: 638604
[No Abstract] [Full Text] [Related]
6. Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin.
Saunders EJ; Saunders JA
Health Care Women Int; 1990; 11(4):423-32. PubMed ID: 2228814
[TBL] [Abstract][Full Text] [Related]
7. Debendox in the dock.
Brown A
Nurs Mirror; 1980 Feb; 150(8):8-9. PubMed ID: 6899313
[No Abstract] [Full Text] [Related]
8. [2 cases of malformations of a limb in infants of mothers treated with an antiemetic in a very early phase of pregnancy].
Soverchia G; Perri PF
Pediatr Med Chir; 1981; 3(1):97-9. PubMed ID: 7301625
[TBL] [Abstract][Full Text] [Related]
9. Return of the morning sickness pill. Could Bendectin be coming back to market?
AWHONN Lifelines; 2001; 5(1):22-3. PubMed ID: 11941692
[No Abstract] [Full Text] [Related]
10. The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects.
McCredie J; Kricker A; Elliott J; Forrest J
Med J Aust; 1984 Apr; 140(9):525-7. PubMed ID: 6708895
[TBL] [Abstract][Full Text] [Related]
11. A new pharmacologic treatment for nausea and vomiting of pregnancy.
Fantasia HC
Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
[TBL] [Abstract][Full Text] [Related]
12. Additional follow-up of congenital limb disorders in relation to Bendectin use.
Aselton PJ; Jick H
JAMA; 1983 Jul; 250(1):33-4. PubMed ID: 6682906
[No Abstract] [Full Text] [Related]
13. Study of prescription drugs in the first trimester and congenital malformations.
McBride WG
Aust N Z J Obstet Gynaecol; 1993 May; 33(2):220. PubMed ID: 8216137
[No Abstract] [Full Text] [Related]
14. Admissibility of scientific testimony into evidence.
Brushwood DB
Am J Hosp Pharm; 1994 Mar; 51(5):683-5. PubMed ID: 8203391
[No Abstract] [Full Text] [Related]
15. Congenital deformities associated with Benedectin.
Patterson DC
Can Med Assoc J; 1977 Jun; 116(12):1348. PubMed ID: 861894
[No Abstract] [Full Text] [Related]
16. Bendectin.
DeSesso JM
Reprod Toxicol; 2001; 15(6):733. PubMed ID: 11738529
[No Abstract] [Full Text] [Related]
17. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen.
Scialli AR
Reprod Toxicol; 1999; 13(4):239. PubMed ID: 10453907
[No Abstract] [Full Text] [Related]
18. Bendectin--birth defects controversy.
Newman SA
JAMA; 1990 Aug; 264(5):569-70. PubMed ID: 2366291
[No Abstract] [Full Text] [Related]
19. Dr. Brent and scientific debate.
Newman SA
Reprod Toxicol; 1999; 13(4):241-4. PubMed ID: 10453908
[No Abstract] [Full Text] [Related]
20. Science, law, and the search for truth in the courtroom: lessons from Daubert v. Merrell Dow.
Bertin JE; Henifin MS
J Law Med Ethics; 1994; 22(1):6-20. PubMed ID: 8173660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
